What is the current market size and future outlook for the antimicrobial resistance surveillance market?
The antimicrobial resistance surveillance market size has grown strongly in recent years. It will grow from $6.77 billion in 2024 to $7.36 billion in 2025 at a compound annual growth rate (CAGR) of 8.7%. The growth in the historic period can be attributed to increased use of antibiotics in agriculture, overprescription of antibiotics in healthcare, lack of diagnostic testing, poor infection prevention and control practices, global travel and trade.
The antimicrobial resistance surveillance market size is expected to see strong growth in the next few years. It will grow to $10.18 billion in 2029 at a compound annual growth rate (CAGR) of 8.5%. The growth in the forecast period can be attributed to growing awareness about antimicrobial resistance, advancements in diagnostic technologies, increasing government initiatives and funding, a rise in healthcare-associated infections, and the development of new antibiotics and alternatives. Major trends in the forecast period include artificial intelligence for data analysis, next-generation sequencing technologies, real-time surveillance systems, molecular diagnostic tools, and the integration of big data and machine learning for predictive modeling.
Get Your Free Sample of The Global Antimicrobial Resistance Surveillance Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21100&type=smp
How has the antimicrobial resistance surveillance market evolved, and what factors have shaped its growth?
The increasing prevalence of infectious diseases is expected to propel the growth of the antimicrobial resistance surveillance market going forward. Infectious diseases are illnesses caused by harmful microorganisms such as bacteria, viruses, fungi, or parasites that can spread directly or indirectly from one individual to another. The rising prevalence of infectious diseases is attributed to factors such as climate change, urbanization, and global travel, which enhance pathogen spread and human exposure to new microbes. Antimicrobial resistance surveillance helps track the spread of resistant pathogens, guiding effective treatment strategies and informing public health policies to combat infectious diseases. For instance, in February 2024, according to a report published by the UK Health Security Agency, a UK-based government agency, tuberculosis (TB) cases in England increased by 10.7% in 2023, with 4,850 cases reported compared to 4,380 in 2022. Therefore, the increasing prevalence of infectious diseases is driving the growth of the antimicrobial resistance surveillance market.
What are the major segments of the antimicrobial resistance surveillance market?
The antimicrobial resistance surveillance market covered in this report is segmented –
1) By Solution: Diagnostic Kits, Diagnostic Systems, Surveillance Software, Services
2) By Application: Clinical Diagnostics, Public Health Surveillance, Other Applications
3) By End User: Hospitals And Clinics, Research And Academic Institutes, Other End Users
Subsegments:
1) By Diagnostic Kits: PCR-Based Kits, Immunoassay Kits, Lateral Flow Assay Kits
2) By Diagnostic Systems: Automated Susceptibility Testing Systems, Whole Genome Sequencing (WGS) Systems, Mass Spectrometry-Based Systems
3) By Surveillance Software: Cloud-Based Surveillance Platforms, AI-Powered Data Analytics Tools, Electronic Health Record (EHR)-Integrated Systems
4) By Services: Laboratory Testing Services, Data Management & Reporting Services, Consultation & Training Services
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/antimicrobial-resistance-surveillance-global-market-report
Which companies dominate the antimicrobial resistance surveillance market?
Major companies operating in the antimicrobial resistance surveillance market are Roche Diagnostics, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Becton, Dickinson and Company, Viatris Inc., Wolters Kluwer NV, Hologic Inc., Biomerieux SA, Bio-Rad Laboratories Inc., Bruker Corporation, Qiagen NV, Cepheid Inc., Shionogi & Co. Ltd., Venatorx Pharmaceuticals Inc., Accelerate Diagnostics Inc., Paratek Pharmaceuticals Inc., Liofilchem Srl, Lumed Inc., OpGen Inc.
How will evolving trends contribute to the growth of the antimicrobial resistance surveillance market?
Major companies operating in the market are focusing on innovative technologies, such as innovative diagnostic tools, to streamline processes, enhance efficiency, improve accuracy, reduce costs, and deliver better outcomes for patients and end-users. A diagnostic tool refers to any device, instrument, software, or methodology used to identify, detect, or assess the presence of a condition, disease, malfunction, or issue. For instance, in June 2023, Sysmex Astrego AB, a Sweden-based manufacturer and supplier of services for diagnostic products, announced the launch of the PA-100 AST Point-of-Care Testing System. This system enables rapid and accurate detection of antimicrobial resistance at the point of care, offering a significant reduction in time compared to traditional laboratory methods, which can take up to several days. By providing results in just 30 minutes, it allows clinicians to make timely and informed decisions about the appropriate treatment for infections, reducing the reliance on broad-spectrum antibiotics and helping to combat the spread of antimicrobial resistance.
What are the key regional dynamics of the antimicrobial resistance surveillance market, and which region leads in market share?
North America was the largest region in the antimicrobial resistance surveillance market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the antimicrobial resistance surveillance market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Antimicrobial Resistance Surveillance Market Report 2025 Offer?
The antimicrobial resistance surveillance market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Antimicrobial resistance (AMR) surveillance refers to the systematic monitoring and tracking of the prevalence and spread of antimicrobial-resistant microorganisms. They are used for detecting emerging resistance patterns, guiding public health interventions, and informing treatment strategies to combat infections caused by resistant bacteria, viruses, and fungi.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21100
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
